Patents by Inventor Michael Shenghan Yu

Michael Shenghan Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR CARDIAC MODELS
    Publication number: 20250101383
    Abstract: The present disclosure provides for in-vitro generated cardiomyocytes, as well as methods of using such cardiomyocytes or variants thereof. The present disclosure also relates to methods of cell co-culture models of cardiac disorders, as well as methods of using such models or variants thereof.
    Type: Application
    Filed: September 19, 2024
    Publication date: March 27, 2025
    Inventors: Alexandre Romain COLAS, Anaïs KERVADEC-BADILLO, Michael Shenghan YU
  • CARDIOGENIC MESODERM FORMATION REGULATORS
    Publication number: 20240110156
    Abstract: This disclosure relates to cardiogenic mesoderm formation regulators and methods of use thereof, e.g., generating a multipotent cardiovascular progenitor cell by overexpressing Id1, Id2, Id3, Id4, Evx1, and/or Grrp1 in a stem cell.
    Type: Application
    Filed: September 26, 2023
    Publication date: April 4, 2024
    Inventors: Alexandre Romain Colas, Mark Mercola, Wesley Lawrence McKeithan, Michael Shenghan Yu
  • Cardiogenic mesoderm formation regulators
    Patent number: 11821003
    Abstract: This disclosure relates to cardiogenic mesoderm formation regulators and methods of use thereof, e.g., generating a multipotent cardiovascular progenitor cell by overexpressing Id1, Id2, Id3, Id4, Evx1, and/or Grrp1 in a stem cell.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: November 21, 2023
    Assignee: Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Alexandre Romain Colas, Mark Mercola, Wesley Lawrence McKeithan, Michael Shenghan Yu
  • CARDIOGENIC MESODERM FORMATION REGULATORS
    Publication number: 20200332260
    Abstract: This disclosure relates to cardiogenic mesoderm formation regulators and methods of use thereof, e.g., generating a multipotent cardiovascular progenitor cell by overexpressing Id1, Id2, Id3, Id4, Evx1, and/or Grrp1 in a stem cell.
    Type: Application
    Filed: August 13, 2018
    Publication date: October 22, 2020
    Inventors: Alexandre Romain Colas, Mark Mercola, Wesley Lawrence McKeithan, Michael Shenghan Yu